Disclosure(s): No financial relationships to disclose
Disclosure(s):
Andrew Rothstein, OD: No financial relationships to disclose
This course explores strategies for differentiating typical multiple sclerosis (MS)-related optic neuritis from atypical forms, including neuromyelitis optica (NMO)- and myelin oligodendrocyte glycoprotein antibody associated disease (MOG). Attendees will learn to identify key clinical features, laboratory findings, and MRI characteristics that differentiate these conditions. Treatment and referral recommendations will also be discussed.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Understand the distinct pathophysiological mechanisms and disease processes underlying optic neuritis secondary to multiple sclerosis, neuromyelitis optica (NMO), and myelin oligodendrocyte glycoprotein antibody disease (MOG)
Differentiate between typical and atypical optic neuritis based on key clinical features, diagnostic tests, and patient history/demographics.
Effectively manage/refer patients presenting with suspected neuromyelitis optica (NMO)- or myelin oligodendrocyte glycoprotein antibody disease (MOG)-associated optic neuritis in the primary care optometry setting
